“Haematology BMT” typically refers to Hematopoietic Stem Cell Transplantation (HSCT) or Bone Marrow Transplantation (BMT) within the field of hematology. This procedure involves the transplantation of hematopoietic stem cells, usually derived from bone marrow, peripheral blood, or umbilical cord blood, to replace damaged or diseased bone marrow. It’s commonly used in treating various hematologic conditions like leukemia, lymphoma, multiple myeloma, and some non-malignant conditions like aplastic anemia and certain immune system disorders. The goal is to replace the diseased or damaged bone marrow with healthy stem cells to allow the body to produce normal blood cells.

The process involves several stages, including the collection of stem cells from the patient (autologous transplant) or a donor (allogeneic transplant), conditioning or preparative regimen which may involve chemotherapy, radiation, or both to destroy the existing bone marrow, and then infusion of the harvested stem cells. After the transplant, patients are closely monitored for potential complications like graft-versus-host disease (in allogeneic transplants) and infections due to weakened immune systems.

It’s a complex procedure that requires specialized medical expertise and facilities. The outcomes can vary based on various factors like the type of disease, the health of the patient, and the success of engraftment.